menu search

Pfizer's (pfe) alopecia areata drug litfulo receives eu nod

Pfizer (PFE) gets marketing authorization in the EU for Litfulo to treat adults and adolescent patients aged 12 years and older with severe alopecia a...

September 19, 2023, 11:18 am

Water supplies stretched to limit during last year's drought, greenpeace report shows

Water utilities were close to breaking the terms of their licences to keep supplies flowing during last year's drought, according to a new report from...

August 23, 2023, 10:27 am

Shareholder investigation: halper sadeh llc investigates reta, ael, prds, cell

NEW YORK, Aug. 20, 2023 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential vio...

August 20, 2023, 7:40 pm

Brodsky & smith shareholder update: notifying investors of the following investigations: echostar corporation (nasdaq – sats), sovos brands, inc. (nasdaq – sovo), reata pharmaceuticals, inc. (nasdaq –

BALA CYNWYD, Pa., Aug. 08, 2023 (GLOBE NEWSWIRE) — Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to ...

August 8, 2023, 8:33 pm

Brodsky & smith shareholder update: notifying investors of the following investigations: echostar corporation (nasdaq – sats), sovos brands, inc. (nasdaq – sovo), reata pharmaceuticals, inc. (nasdaq –

BALA CYNWYD, Pa., Aug. 08, 2023 (GLOBE NEWSWIRE) — Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to ...

August 8, 2023, 8:33 pm

Shareholder investigation: halper sadeh llc investigates reta, eqrx, dffn

NEW YORK, Aug. 03, 2023 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential vio...

August 3, 2023, 10:23 am

Cpmg inc acquires significant stake in reata pharmaceuticals inc

CPMG Inc (Trades, Portfolio), a prominent investment firm, recently expanded its portfolio with the acquisition of a substantial number of shares in <...

August 1, 2023, 10:03 pm

Biogen's just made its biggest acquisition. here's what you need to know.

Biogen's revenue has been on the decline as the company relies on older products that are losing exclusivity. The acquisition of ...

August 1, 2023, 5:45 am

Biogen to buy rare-disease drugmaker reata in $7.3b deal

Yahoo Finance Health Care Reporter Anjalee Khemlani reports on Biogen buying rare-disease drugmaker reata...

July 28, 2023, 5:26 pm

Biogen buys reata pharmaceuticals, expanding its lineup of rare disease drugs

Biogen said it was buying reata Pharmaceuticals for $7.3 billion, expanding its rare disease treatment ...

July 28, 2023, 4:40 pm

Biogen's alzheimer's drug is the biggest growth catalyst for the stock, says jefferies' yee

Michael Yee, Jefferies biotech analyst, joins 'Power Lunch' to discuss what Biogen's purchase of reata ...

July 28, 2023, 3:27 pm

Why biogen agreed to acquire reata for $7.3 billion

Biogen agreed to acquire reata Pharmaceuticals for $7.3 billion, including debt, to expand its rare di...

July 28, 2023, 2:45 pm

reata pharmaceuticals stock opened 50% up on friday: what happened?

Shares of reata Pharmaceuticals Inc (NASDAQ: RETA) opened more than 50% up this morning after Biogen In...

July 28, 2023, 12:49 pm

Why is reata pharmaceuticals (reta) stock up 53% today?

reata Pharmaceuticals (NASDAQ: RETA ) stock is soaring higher on Friday as investors react to an acquis...

July 28, 2023, 10:23 am

Biogen looks to bulk up rare disease portfolio with $7.3 billion acquisition

Biogen will buy reata Pharmaceuticals and its Friedreich's ataxia drug in a $7.3 billion deal....

July 28, 2023, 9:45 am

reata stock surges. biogen is buying it for $7.3 billion in cash.

Biogen will acquire reata for $172.50 a share in cash, expanding its portfolio of neuromuscular disease...

July 28, 2023, 8:02 am

Biogen to buy reata for $6.5 bln to bulk up rare disease portfolio

Biogen said it would buy biotech firm reata Pharmaceuticals for roughly $6.5 billion to expand its pres...

July 28, 2023, 7:21 am

Biogen agrees to acquire reata pharmaceuticals for $7.3 billion in cash

Biogen Inc. BIIB, -0.93% said Friday it has agreed to acquire reata Pharmaceuticals Inc. RETA, +2.32% f...

July 28, 2023, 7:16 am

The great market miscalculation: pfizer's true value remains untapped

Ngenla, a long-acting medicine for treating children with growth hormone deficiency, has been approved by the FDA for use in the United States, adding...

June 30, 2023, 9:15 am

reata pharmaceuticals, inc. (reta) moves 7.0% higher: will this strength last?

reata Pharmaceuticals, Inc. (RETA) witnessed a jump in share price last session on above-average tradin...

June 29, 2023, 7:38 am


Search within

Pages Search Results: